Ethyl 6-bromoimidazo[1,2-a]pyrimidine-2-carboxylate is primarily utilized in pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and oncological disorders. Its structure is valuable in the design of molecules that interact with specific enzymes or receptors, making it a crucial component in drug discovery efforts. Additionally, it is employed in organic synthesis to create more complex heterocyclic compounds, which are often explored for their potential therapeutic applications.